Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pressure Biosciences Inc (OP:PBIO)

0.0006 UNCHANGED
Streaming Delayed Price Updated: 3:50 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pressure Biosciences Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Pressure BioSciences to Participate in FORCE Family Office's January 20th Webinar: Innovations and Advancements in the $4.6 Billion CBD Market
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Fireside Chat SOUTH EASTON, MA / ACCESSWIRE / January 19, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI"... 
From Pressure BioSciences Inc.
Via AccessWire
News headline image
This Company Believes Physics, Not Chemistry, Is the Best Way To Develop Successful Protein Therapeutics ↗
Picture credit: Michael Longmire on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing... 
Via Benzinga
News headline image
Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability ↗
UST Platform's Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets South Easton, MA, December 22, 2021 – Pressure BioSciences, Inc. (... 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Scalable UST(TM) Process Shown to Create Rock-Solid 18-Month Stability
Via Investor Brand Network
News headline image
Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability
UST Platform's Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets SOUTH EASTON, MA / ACCESSWIRE / December 22, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO)... 
From Pressure BioSciences Inc.
Via AccessWire
News headline image
The Use of High Pressure is Transforming the Nutraceuticals (CBD), Food & Beverage, Healthcare, and other Billion-Dollar Markets ↗
Image Provided By Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
News headline image
Is High Pressure Good for Drug Development? ↗
Picture credit: National Cancer Institute The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a... 
Via Benzinga
News headline image
Oil and Water Don't Mix, But This Company - Armed with Newly Awarded Patents and Proprietary Knowhow - Wants to Change That ↗
Photo by Sharon Pittaway on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Topics Intellectual Property
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2021 Financial Report
Via Investor Brand Network
News headline image
Pressure BioSciences, Inc. Q3 Financial Results Maintain Solid 2021 YTD Growth
Operational and Technical Achievements Set Stage for Expected Major Growth and Profitability in 2022 Investor Call Scheduled for Wednesday, November 17, 2021 at 4:30 p.m. ET SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Earnings Regulatory Compliance
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve
Via Investor Brand Network
Topics Intellectual Property
News headline image
Pressure BioSciences Awarded Second U.S. Patent for Its Revolutionary Ultra Shear Technology Platform, for Its Innovative NanoGap Valve
Dynamically-Adaptive Compact Valve is Key Component in the Company's Highly Anticipated and Proprietary UST Platform; UST Expected to Help Deliver Strong Sales Growth and Profitability in 2022 SOUTH... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
Pressure BioSciences' BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI's Protein Refolding Technology ↗
South Easton, MA, November 4, 2021 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale... 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroFold Platform Brings Key Capabilities Amid Strong Demand for Protein Therapeutics
Via Investor Brand Network
Topics Intellectual Property
News headline image
Pressure BioSciences’ BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI’s Protein Refolding Technology
Titans and Emerging Leaders of Biopharma Struggling with Protein Misfolding and Aggregation Issues that Threaten Enormous Revenue Potentials Are Turning to PBI's Uniquely Enabling BaroFold Solution... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at First-of-Its-Kind Benzinga ALL ACCESS Investor Event
Via Investor Brand Network
News headline image
Pressure BioSciences to Participate in the Benzinga ALL ACCESS Investor Event
Company Invites Individual and Institutional Investors, as well as Analysts and Advisors, to Attend Its Live, Virtual Guest Appearance on Thursday, November 4, 2021 SOUTH EASTON, MA / ACCESSWIRE /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance Supply Chain
News headline image
Boston Named World's Top Biotech Hub as the City's Leading Biotech Companies Continue to Make Major Breakthroughs ↗
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
News headline image
Top Astaxanthin Producers Turning to Pressure BioSciences to Increase Quality and Scale Production of World's Most Potent Antioxidant ↗
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Changes Neem Oil into Novel Nanoemulsion through Patented UST Platform
Via Investor Brand Network
News headline image
Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts ↗
Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications... 
Via Benzinga
News headline image
Pressure BioSciences UST Platform Successfully Transforms Neem Oil into a Novel, Highly Potent Nanoemulsion for More Effective Agrochemical Applications
Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Small Cap Conferences
Via Investor Brand Network
News headline image
Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts
Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
News headline image
Pressure BioSciences to Update Investors on Recent Accomplishments, Year-End Goals, Plans for Accelerating Revenue Growth, and Path to Profitability in 2022
Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap Conferences SOUTH EASTON, MA / ACCESSWIRE / September 28, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
News headline image
Pressure BioSciences Partners with Academic and Industry Leaders to Revolutionize Food, Wellness and Biomedical Spaces ↗
Image Provided By Pixabay Pressure BioSciences, Inc. (OTCQB: PBIO), the pioneer behind innovative, broadly applicable pressure-based technologies, has been aggressively pursuing... 
Via Benzinga
News headline image
Pressure BioSciences, Inc. Reports Escalating Quarterly Revenue, Major Progress in Key Platform Technologies, and Formation of Eco-Friendly Agrochem Subsidiary that Already Posted Over $1 Million in Orders ↗
Image Provided By Pexels... 
Via Benzinga
News headline image
Pressure Biosciences Partners with Academic and Industry Leaders to Revolutionize Food, Wellness and Biomedical Spaces ↗
Image Provided By Pixabay Pressure Biosciences, Inc. (OTCQB: PBIO), the pioneer behind innovative, broadly applicable pressure-based technology, has been aggressively pursuing... 
Via Benzinga
News headline image
Pressure BioSciences Reports Strong 2nd Quarter Financial and Business Results; Looks Forward to an Even Stronger 2nd Half of 2021 ↗
Image Provided By Pixabay Pressure BioSciences, ... 
Via Benzinga
News headline image
Pressure BioSciences, Inc. Reports Strong Second Quarter 2021 Financial Results
Significant Growth Reported in Total Revenue (127%), Instrument Sales (178%), and BaroFold/UST Services (298%); Significant Decrease in Operating Loss (51%) Achieved Investor Call Scheduled for... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Earnings Intellectual Property Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.